FindTrial
Sign In

Application of heavy particle in treatment of cervical cancer

Course management of proton heavy particle therapy for early stage cervical cancer with fertility needs

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ONN-17012084
Enrollment
Unknown
Registered
2017-07-22
Start date
2017-09-30
Completion date
Unknown
Last updated
2017-07-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cervical cancer

Interventions

experimental group :heavy particles treatment
control group:surgical treatment

Sponsors

Obstetrics & Gynecology Hospital, Fudan University
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Patients with a diagnosis of cervical squamous cell carcinoma, and tumor stage is IA2 or IB1tumor diameter less than 2cm; Patients with fertility need; Patients can be followed up

Exclusion criteria

Exclusion criteria: Patients with suspicious lymph node metastasis or other site metastasisPatients with with cancerous emboli in the vasculaturePatients with other pathological types and other stages

Design outcomes

Primary

MeasureTime frame
tumor size;Tumor recurrence rate;ovarian function;Cervical function;pregnancy rate;—

Countries

China

Contacts

Public ContactHua Jiang

Obstetrics & Gynecology Hospital, Fudan University

jianghua@fudan.edu.cn+86 13601978182

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026